Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

Study shows promising results for immunotherapy targeting skin cancer

Written by | 28 Apr 2023

A new class of immunotherapy shows promising results for fighting the most aggressive form of skin cancer. The study, published today in Nature Communications by researchers from King’s College London… read more.

Survival rates similar with different treatments of localized prostate cancer

Written by | 21 Apr 2023

Patients who chose active monitoring of their localized prostate cancer have achieved the same high survival rates as those who chose radiotherapy or surgery. Researchers reported these findings… read more.

Female healthworkers need better radiation protection to minimise breast cancer risk

Written by | 20 Apr 2023

Women working in healthcare who are regularly exposed to radiation from x-rays and other imaging procedures need better ionising radiation protection to help minimise their risk of developing breast cancer,… read more.

Gut bacteria play role in CAR-T cancer therapy

Written by | 16 Apr 2023

CAR-T cell therapy has been shown to be highly effective in treating some cancers. However, responses to this relatively new form of immunotherapy can vary, making it difficult… read more.

Study finds “important shortcomings” in official cancer drug information

Written by | 10 Apr 2023

Important information about cancer drug benefits, and related uncertainties, is frequently omitted from official prescription drug information sources for clinicians and patients in Europe, finds an analysis published… read more.

Lighting up tumours could help surgeons remove them more precisely

Written by | 22 Mar 2023

A new technique that combines highly detailed, real-time images of inside the body with a type of infrared light has, for the first time, been used during surgery… read more.

Study: More paid sick leave results in more cancer screenings

Written by | 5 Mar 2023

For most Americans, the two major obstacles to proper medical care are time and money. And while insurance can sometimes reduce healthcare costs, having time to visit the… read more.

More proof that too many medications leads to adversity for older cancer patients

Written by | 2 Mar 2023

When older adults with cancer take multiple medications — including ordinary drugs like blood pressure pills, supplements, or antacids — it can result in more toxic chemotherapy side… read more.

Immunotherapy after surgery provides significant, durable benefit for high-risk bladder patients

Written by | 17 Feb 2023

Immunotherapy after surgery increased bladder cancer patients’ chance of staying cancer-free compared to patients who received a placebo, according to clinical trial results shared in a late-breaking oral… read more.

Study confirms pancreatic cancer rates rising faster in women than men

Written by | 14 Feb 2023

In a large-scale nationwide study, investigators from Cedars-Sinai Cancer have confirmed that rates of pancreatic cancer are rising – and are rising faster among younger women, particularly Black women, than… read more.

One in two cancer patients may develop long COVID, with risk higher in women

Written by | 12 Feb 2023

More than one in two cancer patients at a US cancer centre experienced symptoms of long COVID-19 for more than six months after initial infection, according to a… read more.

New immunotherapy holds promise for ovarian cancer

Written by | 8 Feb 2023

CAR T-cell therapy, a certain kind of cancer treatment in which the immune system’s T cells are programmed to attack tumour cells, is effective in mice with ovarian… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.